FDA.reportPublic FDA data

cabozantinib 100 MG Daily Dose Carton Pack, 4 Blister Cards, 14 Capsules Each

RxCUI
1363409
RxNorm name
cabozantinib 100 MG Daily Dose Carton Pack, 4 Blister Cards, 14 Capsules Each
Display name
cabozantinib 100 MG Daily Dose Carton Pack, 4 Blister Cards, 14 Capsules Each
Full name
cabozantinib 100 MG Daily Dose Carton Pack, 4 Blister Cards, 14 Capsules Each
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
COMETRIQCABOZANTINIBExelixis, Inc.1a0c3bea-c87b-4d25-bb44-5f0174da6b342025-10-18Warnings, Adverse reactionsExact identifier
rxcui: 1363409

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1a0c3bea-c87b-4d25-bb44-5f0174da6b34{28 (cabozantinib 20 MG Oral Capsule) / 28 (cabozantinib 80 MG Oral Capsule) } Pack [GPCK] · cabozantinib 100 MG Daily Dose, 20 MG (28), 80 MG (28) Oral Capsule Pack [PSN] · cabozantinib 100 MG Daily Dose Carton [SY] · cabozantinib 100 MG Daily Dose Carton Pack, 4 Blister Cards, 14 Capsules Each [SY]416These highlights do not include all the information needed to use COMETRIQ safely and effectively. See full prescribing information for COMETRIQ. COMETRIQ ® (cabozantinib) capsules, for oral use Initial U.S. Approval: 201220251018